Accessibility Menu
Avicanna logo

Avicanna

(OTC) AVCNF

Current Price$0.09
Market Cap$12.89M
Since IPO (2019)-96%
5 Year-87%
1 Year-49%
1 Month+5%

Avicanna Financials at a Glance

Market Cap

$12.89M

Revenue (TTM)

CA$25.85M

Net Income (TTM)

-CA$3.59M

EPS (TTM)

-$0.02

P/E Ratio

-4.52

Dividend

$0.00

Beta (Volatility)

0.68 (Low)

Price

$0.09

Volume

66,300

Open

$0.10

Previous Close

$0.10

Daily Range

$0.08 - $0.10

52-Week Range

$0.08 - $0.24

Estimated Earnings Date

May 13, 2026

AVCNF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Avicanna

Industry

Pharmaceuticals

Employees

112

CEO

Aras Azadian, MBA

Headquarters

Toronto, ON M5G 1V2, CA

AVCNF Financials

Key Financial Metrics (TTM)

Gross Margin

51.34%

Operating Margin

-12.95%

Net Income Margin

-13.90%

Return on Equity

-116.09%

Return on Capital

-95.51%

Return on Assets

-16.26%

Earnings Yield

-22.12%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$12.89M

Shares Outstanding

125.79M

Volume

66.30K

Avg. Volume

102.92K

Financials (TTM)

Gross Profit

CA$13.27M

Operating Income

-CA$3.35M

EBITDA

-CA$2.63M

Operating Cash Flow

-CA$2.12M

Capital Expenditure

-CA$128.86K

Free Cash Flow

-CA$2.25M

Cash & ST Invst.

CA$373.06K

Total Debt

CA$0.00

Avicanna Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

CA$6.70M

+5.9%

Gross Profit

CA$3.50M

-2.8%

Gross Margin

52.29%

N/A

Market Cap

$12.89M

N/A

Market Cap/Employee

$148.20K

N/A

Employees

87

N/A

Net Income

-CA$583.15K

-880.4%

EBITDA

-CA$324.55K

-208.4%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

CA$373.06K

-18.3%

Total Debt

CA$0.00

-100.0%

Accounts Receivable

CA$3.48M

+46.6%

Inventory

CA$4.10M

-5.7%

Long Term Debt

CA$0.00

N/A

Short Term Debt

CA$0.00

-100.0%

Return on Assets

-16.26%

N/A

Return on Invested Capital

-25.02%

N/A

Free Cash Flow

-CA$971.85K

-516.2%

Operating Cash Flow

-CA$958.83K

-5321.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
IZOZFIzotropic Corporation
$0.19+2.81%
CNTMFFluent Corp.
$0.02+2.22%
MEDIFMediPharm Labs Corp.
$0.05-3.85%
ISCNFIsracann Biosciences Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
AALAmerican Airlines Group
$17.81-0.02%
TQQQProShares Trust - ProShares UltraPro Qqq
$72.54-0.06%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$40.31+0.06%
CLROClearOne
$7.04+1.19%

Questions About AVCNF

What is the current price of Avicanna?

Avicanna is trading at $0.09 per share.

What is the 52-week range for Avicanna?

Over the past 52 weeks, Avicanna has traded between $0.08 and $0.24.

How much debt does Avicanna have?

As of the most recent reporting period, Avicanna reported total debt of CA$0.00.

How much cash does Avicanna have on hand?

Avicanna reported CA$266.64K in cash and cash equivalents in its most recent financial results.

What is Avicanna’s dividend yield?

Avicanna does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.